The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients

Journal of Nephrology

Volumn 17, Issue 1, 2004, Pages 107-111

  Hackeng, Christian M ^a   Beerenhout, Charles M ^a   Hermans, Marc ^a   Van Der Kuy, P Hugo M ^b   Van Der Dussen, Henk ^a   Van Dieijen Visser, Marja P ^a   Hamulyák, Karly ^a   Van Der Sande, Frank M ^a   Leunissen, Karel M ^a   Kooman, Jeroen P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

C reactive protein; Hemodialysis; Iron parameters; Reticulocyte hemoglobin

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; IRON DEFICIENCY ANEMIA; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; RETICULOCYTE; STATISTICAL ANALYSIS;

AGED; C-REACTIVE PROTEIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INFLAMMATION; IRON; MALE; RENAL DIALYSIS; RETICULOCYTES;

EID: 11144358310     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Besarab A, Amin N, Ahsan M, Vogel SE, Zazuwa G, Frinak S, Zazra JJ, Anandan JV, Gupta A. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 2000; 11: 530-8.
2. Macdougall IC, Tucker B, Thompson J, Tomson CR, Baker LR, Raine AE. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996; 50: 1694-9.
3. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33.
4. Macdougall IC. Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens 1994; 3: 620-5.
5. Beerenhout C, Bekers O, Kooman JP, van der Sande FM, Leunissen KM. A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients. Nephron 2002; 92: 32-5.
6. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13 (suppl 1): S28-36.
7. Worwood M. The laboratory assessment of iron status-un update. Clin Chim Acta 1997; 259: 3-23.
8. Lieu PT, Heiskala M, Peterson PA, Yang Y. The roles of iron in health and disease. Mol Aspects Med 2001; 22: 1-87.
9. Brittenham GM, Weiss G, Brissot P, Lainé F, Guillygomarc'h A, Guyader D, Moirand R, Deugnier Y. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Hematology 2000; XX: 39-50.
10. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-22.
11. Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997; 30: 912-22.
12. Cullen P, Soffker J, Hopfl M, Bremer C, Schlaghecken R, Mehrens T, Assmann G, Schaefer RM. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999; 14: 659-65.
13. Bhandari S, Norfolk D, Brownjohn A, Turney J. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy. Am J Kidney Dis 1997; 30: 814-21.
14. Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002; 99: 1489-91.
15. Domrongkitchaiporn S, Jirakranont B, Atamasrikul K, Ungkanont A, Bunyaratvej A. Indices of iron status in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1999; 34: 29-35.
16. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-13.
17. Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001; 16: 1416-23.
18. Dittrich E, Schillinger M, Sunder-Plassmann G, Hörl WH, Vychytil A. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. Perit Dial Int 2002; 22: 60-6.
19. Kotisaari S, Romppanen J, Penttila I, Punnonen K. The Advia 120 red blood cells and reticulocyte indices are useful in diagnosis of iron-deficiency anemia. Eur J Haematol 2002; 68: 150-6.
20. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48: 1066-76.
21. Jurado RL. Iron, infections and anemia of inflammation. Clin Infect Dis 1997; 25: 888-95.
22. Drueke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001; 16 (suppl 7): S25-8.
23. Kletzmayr J, Horl WH. Iron overload and cardiovascular complications in dialysis patients. Nephrol Dial Transplant 2002; 17 (suppl 2): S25-9.
24. Fishbane S. Review of issues relating to iron and infection. Am J Kidney Dis 1999; 34 (suppl 2): S47-52.
25. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001; 37: 564-72.
26. Drueke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation. 2002; 106: 2212-7.
27. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54: 627-36.
28. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 2001; 37 (suppl 1): S182-238.
29. Macdougall IC, Horl WH, Jacobs C, Valderrabano F, Parrondo I, Thompson K, Cremers S. European Best Practice Guidelines 6-8: Assessing and optimizing iron stores. Nephrol Dial Transplant 2000; 15 (suppl 4): S20-32.